Holmium Laser Enucleation of the Prostate (HoLEP): The Endourologic Alternative to Open Prostatectomy
Tuesday, 24 January 2006
HoLEP represents a safe and effective treatment for patients with symptomatic large prostates.
read more
|
BXL628, A Novel Vitamin D3 Analog Arrests Prostate Growth in Patients with Benign Prostatic Hyperplasia: A Randomized Clinical Trial
Monday, 23 January 2006
BXL628 was able to arrest prostate growth within 12 weeks in men aged =50 years with prostatic volume =40ml.
read more
|
Doxazosin Wth Finasteride Effective Against BPH
Thursday, 12 January 2006
NEW YORK (Reuters Health) - Combination therapy with doxazosin and finasteride is more effective against benign prostatic hyperplasia (BPH) in men with moderate size or enlarged prostates than is either agent alone, researchers report in the January issue of the Journal of Urology.
read more
|
Two Weeks Of Finasteride Treatment Inhibits Prostate Angiogenesis
Wednesday, 21 December 2005
BERKELEY, CA (UroToday.com) - The 5α-reductase inhibitor finasteride blocks the conversion of testosterone to dihydrotestosterone and inhibits expression of androgen-regulated growth factors.
read more
|
Sildenafil Improves Urinary Symptoms In Men With Erectile Dysfunction
Tuesday, 22 November 2005
NEW YORK (Reuters Health) - Treatment with sildenafil (Viagra) can improve urinary tract symptoms in men with erectile dysfunction and benign prostatic hyperplasia (BPH), according to study findings presented here Monday at a meeting of the Sexual Medicine Society of North America.
read more
|
Early Genitourinary Infections In Men May Raise Risk Of Urinary Tract Symptoms
Monday, 14 November 2005
NEW YORK (Reuters Health) - Men who describe a history of gonorrhea or young-onset prostatitis appear to be at increased risk for lower urinary tract symptoms (LUTS) later in life, according to a report in the American Journal of Epidemiology for November 1.
read more
|
Tamsulosin And Naftopidil Equivalent Against BPH
Monday, 03 October 2005
NEW YORK (Reuters Health) - Tamsulosin and naftopidil, two alpha1-blockers with different affinities to the alpha1 adrenoceptor (AR) subtypes, are equally safe and effective for treating the symptoms of benign prostatic hyperplasia (BPH), according to a study conducted in Japan.
read more
|
First Long-Term Study Of Photoselective Vaporization Of The Prostate (PVP) Reinforces Procedure As An Effective, Long-Term Treatment Solution For BPH
Tuesday, 27 September 2005
San Jose, California, September 26, 2005 ? Laserscope (Nasdaq: LSCP), a pioneer in the
development and commercialization of minimally-invasive medical devices, including medical lasers
and advanced fiber-optic delivery devices, today announced the results of a milestone study
evaluating the long-term outcomes of men treated with photoselective vaporization of the prostate
(PVP) for benign prostatic hyperplasia (BPH) using the GreenLight™ laser system.
read more
|
Holmium Laser Enucleation "Ideal" For Urinary Retention Due To BPH
Thursday, 01 September 2005
NEW YORK (Reuters Health) - Holmium laser enucleation of the prostate (HoLEP) may be "the ideal treatment" for men with urinary retention due to benign prostatic hyperplasia (BPH), investigators report based on a retrospective study of 164 consecutive men treated by HoLEP between January 2000 and August 2004.
read more
|
Urologix Announces Agreement For The Development Of Real-Time Imaging System
Monday, 15 August 2005
MINNEAPOLIS, Aug 02, 2005 (BUSINESS WIRE) -- Urologix(R), Inc. (NASDAQ:ULGX), has entered into a co-development agreement with ProUroCare Medical, Inc. (OTCBB:PRRC.OB), and Rensselaer Polytechnic Institute to develop a real-time temperature imaging system, ProUroVision(TM), to be utilized with Urologix' Cooled ThermoTherapy(TM) treatment of benign prostatic hyperplasia (BPH) as well as potential new indications.
read more
|
BPH & Male LUTS 
